Front Row Advisors’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-420
Closed -$11K 963
2022
Q3
$11K Hold
420
0.01% 497
2022
Q2
$11K Hold
420
0.01% 505
2022
Q1
$11K Hold
420
﹤0.01% 544
2021
Q4
$11K Hold
420
﹤0.01% 562
2021
Q3
$11K Hold
420
﹤0.01% 553
2021
Q2
$11K Sell
420
-3,000
-88% -$76.3K ﹤0.01% 552
2021
Q1
$87K Sell
3,420
-1,000
-23% -$25.5K 0.04% 203
2020
Q4
$113K Hold
4,420
0.06% 167
2020
Q3
$113K Buy
4,420
+4,120
+1,373% +$106K 0.06% 167
2020
Q2
$8K Hold
300
0.01% 537
2020
Q1
$8K Hold
300
0.01% 528
2019
Q4
$8K Hold
300
0.01% 519
2019
Q3
$8K Buy
+300
New +$7.57K 0.01% 504

Other funds holding IBDN

Front Row Advisors's IBDN Position: Q4 2022 in Review

Front Row Advisors sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 420 shares — an estimated $11K sold.

Front Row Advisors first reported a position in IBDN in Q3 2019 and held it in 13 quarters. The position peaked at $113K in Q4 2020. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Front Row Advisors reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Front Row Advisors sold 420 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $11K.
  • Front Row Advisors first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q3 2019 and held it in 13 quarters.
  • Front Row Advisors's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $113K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Front Row Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.